Klinikum der Universität München (Großhadern und Innenstadt)

Hospital


Location: München, Germany (DE) DE

ISNI: 0000000404772585

ROR: https://ror.org/02jet3w32

Show on Map:


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Risk of pelvic metastasis and significance of pelvic lymphadenectomy in patients with node-positive vulvar cancer - results of the AGO-VOP.2/QS vulva study (2022) Jaeger A, Hampl M, Zu Eulenburg C, Prieske K, Hambrecht J, Fuerst S, Klapdor R, et al. Conference contribution AGO Recommendations for the Surgical Therapy of Breast Cancer: Update 2022 (2022) Banys-Paluchowski M, Thill M, Kuhn T, Ditsch N, Heil J, Woeckel A, Fallenberg E, et al. Journal article CAR T cells targeting Aspergillus fumigatus are effective at treating invasive pulmonary aspergillosis in preclinical models (2022) Seif M, Kakoschke TK, Ebel F, Bellet MM, Trinks N, Renga G, Pariano M, et al. Journal article Heterogeneity and function of conventional dendritic cells from early to adult life (2022) Schraml B, Papaioannou N, Shakiba R, Ravi K, Kuentzel V, Salei N, Lehman CH, et al. Conference contribution BISPECIFIC ANTIBODIES ENABLE SYNTHETIC AGONISTIC RECEPTOR T CELL THERAPY IN MELANOMA (2022) Benmebarek M, Maerkl F, Keyl J, Cadilha B, Geiger M, Karches C, Obeck H, et al. Conference contribution Treatment of patients with advanced urothelial carcinoma in routine care in Germany: initial data from the CARAT-UBC cohort (2022) Goebell P, Mueller L, Boegemann M, Rauh J, Nusch A, Andres-Pons A, Hamm N, et al. Conference contribution Steigerung der zytotoxischen Aktivitat eines CD19 Antikorpers durch duale Fc-Optimierung (2022) Gehlert CL, Rahmati P, Boje AS, Winterberg D, Krohn S, Theocharis T, Nimmerjahn F, et al. Conference contribution Increased CD47 expression inhibits phagocytosis of alloreactive donor T cells after allo-HSCT (2022) Flamann C, Matos C, Kreutz M, Shaikh H, Beilhack A, Büttner-Herold M, Lischer C, et al. Conference contribution SOX10-based drug repurposing identifies novel therapeutic targets in uveal melanoma (2022) Wessely A, Kammerbauer C, Lischer C, Weich A, Vera J, Berking C, Heppt M Conference contribution Development of a national strategy with recommendations for the care of seriously ill and dying people and their relatives in pandemics: A modified Delphi study (2022) Gauder S, Pralong A, Remi C, Hodiamont F, Klinger I, Heckel M, Simon ST, Bausewein C Journal article